Noradrenaline: Friend or foe?

Heart Lung and Circulation

Volumn 12, Issue SUPPL. 2, 2003, Pages

  Bellomo, Rinaldo ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Acute renal failure; Cardiac surgery; Noradrenaline

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ENDOTOXIN; HYPERTENSIVE AGENT; INDOMETACIN; NORADRENALIN; PROPRANOLOL;

ACUTE KIDNEY FAILURE; ARTERIAL PRESSURE; ARTICLE; BRAIN PERFUSION; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HEART SURGERY; HUMAN; HYPOTENSION; INFLAMMATION; INTESTINE BLOOD FLOW; KIDNEY BLOOD FLOW; KIDNEY TUBULE PRESSURE; LOW DRUG DOSE; NONHUMAN; ORGAN BLOOD FLOW; PERFUSION PRESSURE; PRIORITY JOURNAL; SEPTIC SHOCK; URINE VOLUME; VASOCONSTRICTION; VASODILATATION;

EID: 0348161077     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-9506.2003.t01-7-.x     Document Type: Article

References (31)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1658-62.
2. Schreuder WO, Schneider AJ, Groeneveld ABJ et al. Effect of dopamine vs. norepinephrine on hemodynamics in septic shock. Chest 1989; 95: 1282-8.
3. Martin C, Papazian L, Perrin G et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103: 1826-31.
4. Desjars P, Pinaud M, Potel G et al. A reappraisal of norepinephrine therapy in human septic shock. Crit. Care Med. 1987; 15: 134-7.
5. Moran JLO, Fathartaigh M, Peisach AR et al. Epinephrine as an inotropic agent in septic shock: a dose profile analysis. Crit. Care Med. 1993; 21: 70-7.
6. Pawlik W, Sheperd AP, Jacobson ED. Effect of vasoactive agents on intestinal oxygen consumption and blood flow in dogs. J. Clin. Invest. 1975; 56: 484-90.
7. Shepherd AP, Pawlik W, Mailman D, Burks TF, Jacobson ED. Effects of vasoconstrictors on intestinal vascular resistance and oxygen extraction. Am. J. Physiol. 1976; 230: 298-303.
8. Gombos EA, Hulet WH, Bopp P et al. Reactivity of renal and systemic circulations to vasoconstrictor agents in normotensive and hypertensive subjects. J. Clin. Invest. 1962; 41: 203-7.
9. Mills LC, Moyer JH, Handley CA. Effects of various sympathomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am. J. Physiol. 1960; 198: 1279-85.
10. Richer M, Robert S, Lebel M. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit. Care Med. 1996; 24: 1150-6.
11. Deitch EA, Winterton J, Bey R. The gut as the portal of entry for bacteremia. Ann. Surg. 1987; 205: 681-92.
12. Schott CA, Gray GA, Stoclet JC. Dependence of endotoxin - induced vascular hyporeactivity on extracellular 1-arginine. Br. J. Pharmacol. 1993; 108: 38-43.
13. Kilbourn RO, Gross SS, Jubran A et al. N-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 1990; 87: 3629-32.
14. Vallet B, Lund N, Curtis SE, Kelly D, Cain SM. Gut and muscle tissue PO2 in endotoxemic dogs during shock and resuscitation. J. Appl. Physiol. 1994; 76: 793-800.
15. Cronin RE, De Torrente A, Miller PD, Bulger RE, Burke TJ, Schrier RW. Pathogenic mechanisms in early norepinepherine-induced acute renal failure: functional and histological correlates of protection. Kidney Int. 1978; 14: 115-25.
16. Cronin R, Erickson AM, De Torrente A, McDonald KM, Schrier RW. Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal failure. Kidney Int. 1978; 14: 187-90.
17. Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit. Care Med. 1985; 13: 492-6.
18. Anderson WP, Korner PI, Selig SE. Mechanisms involved in the renal responses to intravenous and renal artery infusions of noradrenaline in conscious dogs. J. Physiol. 1981; 321: 21-30.
19. Korner PI, Dorward PK, Blombery PA, Frean GJ. Central nervous beta-adrenoreceptors and their role in the cardiovascular action of propranolol in rabbits. Circulation Res. 1967; 20: 676-85.
20. Zhang H, Smail N, Cabral A, Rogiers P, Vincent J-L. Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxic shock. Am. J. Resp. Crit. Care Med. 1997; 155: 1965-71.
21. Bersten AD, Rutten AJ. Renovascular interaction of epinephrine, dopamine, and intraperitoneal sepsis. Crit. Care Med. 1995; 23: 537-44.
22. Bersten AD, Rutten AJ, Summersides G et al. Epinephrine infusion in the sheep: systemic and renal hemodynamic effects. Crit. Care Med. 1994; 22: 994-1001.
23. Bellomo R, Kellum JA, Wisniewski SR, Pinsky MR. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am. J. Respir. Crit. Care Med. 1999; 159: 1186-92.
24. Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit. Care Med. 1989; 17: 179-80.
25. Meadows D, Edwards JD, Wilkins RG et al. Reversal of intractable septic shock with norepinephrine therapy. Crit. Care Med. 1988; 16: 663-6.
26. Martin C, Eon B, Saux P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients. Crit. Care Med. 1990; 18: 282-5.
27. Desjars P, Pinaud M, Bugnon D, Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit. Care Med. 1990; 18: 1048-9.
28. Rudis MI, Basha MA, Zarowitz BJ. Is it time to reposition vasopressors and inotropes in sepsis? Crit. Care Med. 1996; 24: 525-37.
29. Redl-wenzel EM, Armbruster C, Edelmann G et al. The effects of norepinephrine on hemodynamics and renal function in severe shock states. Intensive Care Med. 1993; 19: 151-4.
30. Bellomo R, Ronco C. The use of inotropic and vasopressor agents in patients at risk of renal dysfunction. In: Ronco, C, Bellomo, R, eds. Critical care nephrology. Dordrecht: Kluwer Academic Publishers, 1998; 1133-8.
31. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit. Care Med. 2000; 28: 2758-65.